NIH Pans Hydroxychloroquine, Sets Up Multiple New Media Narratives

Yet another highly-predictable outcome. – Late Tuesday, a panel of “experts” – the same kind of “experts” who assured us just a month ago that the Wuhan Virus would kill 2 million Americans – announced their disapproval for hydroxychloroquine in combination with axithromycin as a treatment for the Wuhan Virus.

Here’s an excerpt from an NPR report on the matter:

A panel of experts convened by the National Institute of Allergy and Infectious Diseases recommends against doctors using a combination of hydroxychloroquine and azithromycin for the treatment of COVID-19 patients because of potential toxicities.

“The combination of hydroxychloroquine and azithromycin was associated with QTc prolongation in patients with COVID-19,” the panel said.

QTc prolongation increases the risk of sudden cardiac death.

The recommendation against their combined use would seem to fly in the face of comments made by President Trump suggesting the combination might be helpful. On March 21, for example, the president described them in a tweet as having a “real chance to be one of the biggest game changers in the history of medicine.”

[End]

In English, the QTc prolongation means that HCQ can be dangerous for people who suffer from irregular heartbeats, an affliction most common among seniors, who are already vulnerable to the virus. This is in fact a long-known side effect of HCQ.